FDA seeks feedback on voucher program; Study data lift ‘overhang’ on Insmed shares

Industry executives can share their views on the “national priority” program at a June meeting. Elsewhere, Sanofi licensed a T cell engager and Acorda’s former CEO resurfaced at a cell therapy startup.

Continue reading →